EPHA5 and benign prostatic hyperplasia: Downregulation or loss of EPHA5 mRNA or protein expression detected in 62.2% PCa tissues and 5.1% BPH tissuesFrequency of EPHA5 DNA methylation was higher in cancer patients with an elevated Gleason score or T3–T4 disease stage